Methylation and expression quantitative trait loci rs1799971 in the OPRM1 gene and rs4654327 in the OPRD1 gene are associated with opioid use disorder

[1]  M. Goddard,et al.  Genetic variation in histone modifications and gene expression identifies regulatory variants in the mammary gland of cattle , 2022, BMC genomics.

[2]  S. Ingram,et al.  Key differences in regulation of opioid receptors localized to presynaptic terminals compared to somas: Relevance for novel therapeutics , 2022, Neuropharmacology.

[3]  N. Mancuso,et al.  Incorporation of DNA methylation quantitative trait loci (mQTLs) in epigenome-wide association analysis: application to birthweight effects in neonatal whole blood , 2022, Clinical Epigenetics.

[4]  R. Rosenthal,et al.  An integrated LSTM-HeteroRGNN model for interpretable opioid overdose risk prediction , 2022, Artif. Intell. Medicine.

[5]  Gregor Bieri,et al.  Loss of neuronal Tet2 enhances hippocampal-dependent cognitive function , 2022, Cell reports.

[6]  M. Momeny,et al.  The DNA Methylation in Neurological Diseases , 2022, Cells.

[7]  A. Børglum,et al.  Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci , 2022, Molecular Psychiatry.

[8]  Chathura Gunasekara,et al.  Systemic interindividual epigenetic variation in humans is associated with transposable elements and under strong genetic control , 2022, bioRxiv.

[9]  Jingwei Tian,et al.  MicroRNAs in drug addiction: Current status and future perspectives. , 2022, Pharmacology & therapeutics.

[10]  Rui Zhang,et al.  Methylation and expression quantitative trait locus rs6296 in the HTR1B gene is associated with susceptibility to opioid use disorder , 2022, Psychopharmacology.

[11]  Jun B. Ding,et al.  Dichotomous regulation of striatal plasticity by dynorphin , 2022, bioRxiv.

[12]  G. Paré,et al.  A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder , 2021, Addiction Science & Clinical Practice.

[13]  J. Neumaier,et al.  Stress decreases serotonin tone in the nucleus accumbens in male mice to promote aversion and potentiate cocaine preference via decreased stimulation of 5-HT1B receptors , 2021, Neuropsychopharmacology.

[14]  A. Szalay,et al.  Genome-wide sequencing-based identification of methylation quantitative trait loci and their role in schizophrenia risk , 2021, Nature Communications.

[15]  Zhongming Zhao,et al.  Genome-Wide Correlation of DNA Methylation and Gene Expression in Postmortem Brain Tissues of Opioid Use Disorder Patients , 2021, The international journal of neuropsychopharmacology.

[16]  O. Levran,et al.  OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics , 2021, Translational Psychiatry.

[17]  W. Abraham,et al.  Glutamate receptors and metaplasticity in addiction. , 2020, Current opinion in pharmacology.

[18]  L. Farrer,et al.  Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study. , 2020, JAMA psychiatry.

[19]  L. Farrer,et al.  Prefrontal cortex eQTLs/mQTLs enriched in genetic variants associated with alcohol use disorder and other diseases. , 2020, Epigenomics.

[20]  P. Keshavarz,et al.  Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment , 2019, Journal of Molecular Neuroscience.

[21]  Sajjad Rezaei,et al.  Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population , 2017, Journal of addictive diseases.

[22]  Youxin Wang,et al.  Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese. , 2017, Omics : a journal of integrative biology.

[23]  B. Balleine,et al.  Chronic Morphine Reduces Surface Expression of δ-Opioid Receptors in Subregions of Rostral Striatum , 2016, Neurochemical Research.

[24]  L. Bierut,et al.  Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1 , 2015, Biological Psychiatry.

[25]  Lilian Enriquez-Barreto,et al.  Gene expression parallels synaptic excitability and plasticity changes in Alzheimer’s disease , 2015, Front. Cell. Neurosci..

[26]  Eric J. Nestler,et al.  Epigenetic mechanisms of drug addiction , 2014, Neuropharmacology.

[27]  N. Wray,et al.  Association of OPRD1 polymorphisms with heroin dependence in a large case‐control series , 2014, Addiction biology.

[28]  H. Ulmer,et al.  Association of Polymorphisms in Pharmacogenetic Candidate Genes (OPRD1, GAL, ABCB1, OPRM1) with Opioid Dependence in European Population: A Case-Control Study , 2013, PloS one.

[29]  A. Doehring,et al.  Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain , 2013, PAIN®.

[30]  M. Lynskey,et al.  Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts. , 2011, Journal of opioid management.

[31]  J. Ott,et al.  Genetic susceptibility to heroin addiction: a candidate gene association study , 2008, Genes, brain, and behavior.

[32]  B. Cravatt,et al.  A missense mutation in human fatty acid amide hydrolase associated with problem drug use , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Brigitte L. Kieffer,et al.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene , 1996, Nature.

[34]  F. Rösl,et al.  The effect of DNA methylation on gene regulation of human papillomaviruses. , 1993, The Journal of general virology.

[35]  J. Rasko,et al.  DNA methylation/hydroxymethylation regulate gene expression and alternative splicing during terminal granulopoiesis. , 2019, Epigenomics.

[36]  Genome-wide association study identi fi es Sjögren ’ s risk loci with functional implications in immune and glandular cells , 2022 .